Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
7.600
-0.010 (-0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angiodynamics Inc
< Previous
1
2
3
4
5
6
7
Next >
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
July 16, 2024
Via
Benzinga
Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
July 16, 2024
AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company...
Via
Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
July 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
July 16, 2024
Via
Benzinga
ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024
July 16, 2024
ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via
InvestorPlace
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
July 16, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
July 08, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Insiders Buying Zumiez And 3 Other Stocks
April 09, 2024
Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.
Via
Benzinga
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
April 04, 2024
FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees...
Via
Benzinga
Exposures
Product Safety
ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
April 04, 2024
ANGO stock results show that AngioDynamics missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!
Via
InvestorPlace
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For April 4, 2024
April 04, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.
Via
Benzinga
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
April 02, 2024
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 01, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
March 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.
Via
InvestorPlace
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
February 15, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
February 11, 2024
The medical device maker's shares have seen an increase of 1.49% over the last month, not keeping up with the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
January 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know
January 09, 2024
Via
Benzinga
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
January 08, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why AngioDynamics Stock Got Destroyed Today
January 05, 2024
The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected.
Via
The Motley Fool
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.